Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Sep;33(3):743–749. doi: 10.1128/iai.33.3.743-749.1981

Recovery of mice from herpes simplex virus type 2 hepatitis: adoptive transfer of recovery with immune spleen cells.

S C Mogensen, H K Andersen
PMCID: PMC350772  PMID: 6269998

Abstract

Young BALB/c mice inoculated intraperitoneally with herpes simplex virus type 2 develop focal necrotizing hepatitis. After infection, the livers of these mice show increasing virus titers, which reach a maximum on day 3 after infection; this is followed by a dramatic decrease in the amount of virus recovered on days 4 and 5. This decrease in virus content is accompanied by a progressive infiltration of the lesions with mononuclear leukocytes and an apparent resolution of the lesions. Adoptive transfer of immune spleen cells from mice infected 6 days earlier accelerated this process. When 50 x 10(6) to 100 x 10(6) immune spleen cells were transferred 24 h after infection, the inflammatory response and the clearance of virus from the livers were advanced by almost 2 days. As few as 12 x 10(6) immune spleen cells accelerated the healing process, whereas fewer immune cells, disrupted immune cells, or normal spleen cells did not have an effect. The protection conferred by herpes simplex virus type 2-sensitized immune spleen cells was specific since mouse cytomegalovirus- or vaccinia virus-sensitized immune spleen cells had no effect on the course of infection with herpes simplex virus type 2, whereas some cross-reactivity was observed between herpes simplex virus types 1 and 2. This model seems to be suitable for examining the immunological mechanisms that are active during recovery from visceral herpes simplex virus infections.

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev. 1974;19(0):3–55. doi: 10.1111/j.1600-065x.1974.tb00127.x. [DOI] [PubMed] [Google Scholar]
  2. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ennis F. A. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis. 1973 Jun;127(6):632–638. doi: 10.1093/infdis/127.6.632. [DOI] [PubMed] [Google Scholar]
  4. Howes E. L., Taylor W., Mitchison N. A., Simpson E. MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature. 1979 Jan 4;277(5691):66–68. doi: 10.1038/277067a0. [DOI] [PubMed] [Google Scholar]
  5. McFarland H. F., Griffin D. E., Johnson R. T. Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med. 1972 Aug 1;136(2):216–226. doi: 10.1084/jem.136.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Merigan T. C. Host defenses against viral disease. N Engl J Med. 1974 Feb 7;290(6):323–329. doi: 10.1056/NEJM197402072900608. [DOI] [PubMed] [Google Scholar]
  7. Mogensen S. C., Andersen H. K. Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice. Infect Immun. 1977 Aug;17(2):274–277. doi: 10.1128/iai.17.2.274-277.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mogensen S. C., Andersen H. K. Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2. Infect Immun. 1978 Mar;19(3):792–798. doi: 10.1128/iai.19.3.792-798.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mogensen S. C. Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus types 1 and 2. Acta Pathol Microbiol Scand B. 1976 Jun;84(3):154–158. [PubMed] [Google Scholar]
  10. Mogensen S. C. Genetics of macrophage-controlled resistance to hepatitis induced by herpes simplex virus type 2 in mice. Infect Immun. 1977 Aug;17(2):268–273. doi: 10.1128/iai.17.2.268-273.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mogensen S. C. Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 im mice. Infect Immun. 1978 Jan;19(1):46–50. doi: 10.1128/iai.19.1.46-50.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mogensen S. C. Role of macrophages in natural resistance to virus infections. Microbiol Rev. 1979 Mar;43(1):1–26. doi: 10.1128/mr.43.1.1-26.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mogensen S. C., Teisner B., Andersen H. K. Focal necrotic hepatitis in mice as a biological marker for differentiation of Herpesvirus hominis type 1 and type 2. J Gen Virol. 1974 Oct;25(1):151–155. doi: 10.1099/0022-1317-25-1-151. [DOI] [PubMed] [Google Scholar]
  14. Mogensen S. Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice. Infect Immun. 1977 Mar;15(3):686–691. doi: 10.1128/iai.15.3.686-691.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973 Sep 27;289(13):667–674. doi: 10.1056/NEJM197309272891305. [DOI] [PubMed] [Google Scholar]
  16. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med. 1973 Oct 11;289(15):781–789. doi: 10.1056/NEJM197310112891505. [DOI] [PubMed] [Google Scholar]
  17. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. II. N Engl J Med. 1973 Oct 4;289(14):719–725. doi: 10.1056/NEJM197310042891404. [DOI] [PubMed] [Google Scholar]
  18. Oakes J. E. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect Immun. 1975 Jul;12(1):166–172. doi: 10.1128/iai.12.1.166-172.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol. 1976 Jan;116(1):35–40. [PubMed] [Google Scholar]
  20. Welsh R. M., Jr, Zinkernagel R. M. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature. 1977 Aug 18;268(5621):646–648. doi: 10.1038/268646a0. [DOI] [PubMed] [Google Scholar]
  21. Worthington M., Conliffe M. A., Baron S. Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis. 1980 Aug;142(2):163–174. doi: 10.1093/infdis/142.2.163. [DOI] [PubMed] [Google Scholar]
  22. Yap K. L., Ada G. L. The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand J Immunol. 1978;7(5):389–397. doi: 10.1111/j.1365-3083.1978.tb00469.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES